Christopher Hite
EVP & Chairman, Partnering · Royalty Pharma plc
- 2025
- Sep 24, 2026
- 11
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Christopher Hite files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Terrance P. Coyne - $33.61M in RPRX purchases and sales in the last 12 months
- George W. Lloyd - $9.57M in RPRX purchases and sales in the last 12 months
- Marshall Urist - $7.01M in RPRX purchases and sales in the last 12 months
- Gregory Norden - $161K in RPRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Christopher Hite?
Christopher Hite is a corporate insider, tracked as EVP & Chairman, Partnering of Royalty Pharma plc (RPRX). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Christopher Hite submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Christopher Hite been buying or selling stock?
Recorded transactions: 0 open-market purchases and 9 open-market sales ($27.36M) across all tracked filings.
